Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fontaine

Showing results (241-250 of 243) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 243 results.
The British Journal of Surgery|April 1, 2018
Multicentre randomized clinical trial of inspiratory muscle training versus usual care before surgery for oesophageal cancerK Valkenet, J C A Trappenburg, J P Ruurda, et al.
Journal of Medicinal Chemistry|July 30, 2024
Genomic Discovery and Structure-Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase InhibitorsJack R Davison, Michalis Hadjithomas, Stuart P Romeril, et al.
Science Advances|July 3, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.
Pageof 25

Showing results (241-250 of 243) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 243 results.
The British Journal of Surgery|April 1, 2018
Multicentre randomized clinical trial of inspiratory muscle training versus usual care before surgery for oesophageal cancerK Valkenet, J C A Trappenburg, J P Ruurda, et al.
Journal of Medicinal Chemistry|July 30, 2024
Genomic Discovery and Structure-Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase InhibitorsJack R Davison, Michalis Hadjithomas, Stuart P Romeril, et al.
Science Advances|July 3, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy responseBrooke A Pereira, Shona Ritchie, Cecilia R Chambers, et al.
Pageof 25